Completed PHASE2 NCT00149604

AFTER: Altering Fat Through Estrogen and Raloxifene

Modulation of Visceral Fat by Estrogens After Menopause

Sponsor: National Institute on Aging (NIA)

Interventions Raloxifene conjugated estrogens exercise plus mild caloric restriction for weight loss

Updated 5 times since 2017 Last updated: Dec 1, 2009 Started: Mar 31, 2000 Primary completion: Feb 28, 2006 Completion: Feb 28, 2006

This PHASE2 trial investigates Postmenopause and is currently completed. National Institute on Aging (NIA) leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Aging (NIA)

Data source: National Institute on Aging (NIA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Denver, United States